BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 16475990)

  • 1. The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-alpha-stimulated host cells.
    Hartwig D; Schütte C; Warnecke J; Dorn I; Hennig H; Kirchner H; Schlenke P
    J Viral Hepat; 2006 Mar; 13(3):150-7. PubMed ID: 16475990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha stimulation of liver cells enhances hepatitis delta virus RNA editing in early infection.
    Hartwig D; Schoeneich L; Greeve J; Schütte C; Dorn I; Kirchner H; Hennig H
    J Hepatol; 2004 Oct; 41(4):667-72. PubMed ID: 15464249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1.
    Wong SK; Lazinski DW
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15118-23. PubMed ID: 12399548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1.
    Taylor DR; Puig M; Darnell ME; Mihalik K; Feinstone SM
    J Virol; 2005 May; 79(10):6291-8. PubMed ID: 15858013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase.
    Polson AG; Bass BL; Casey JL
    Nature; 1996 Apr; 380(6573):454-6. PubMed ID: 8602246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.
    Jayan GC; Casey JL
    J Virol; 2002 Apr; 76(8):3819-27. PubMed ID: 11907222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
    Liu Y; Wolff KC; Jacobs BL; Samuel CE
    Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression.
    Jayan GC; Casey JL
    J Virol; 2002 Dec; 76(23):12399-404. PubMed ID: 12414985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of conserved RNA secondary structures on hepatitis delta virus genotype I RNA editing, replication, and virus production.
    Jayan GC; Casey JL
    J Virol; 2005 Sep; 79(17):11187-93. PubMed ID: 16103170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy.
    Yang W; Wang Q; Kanes SJ; Murray JM; Nishikura K
    Brain Res Mol Brain Res; 2004 Apr; 124(1):70-8. PubMed ID: 15093687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis delta virus inhibits alpha interferon signaling.
    Pugnale P; Pazienza V; Guilloux K; Negro F
    Hepatology; 2009 Feb; 49(2):398-406. PubMed ID: 19085955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of a metastable RNA secondary structure in hepatitis delta virus genotype III RNA editing.
    Linnstaedt SD; Kasprzak WK; Shapiro BA; Casey JL
    RNA; 2006 Aug; 12(8):1521-33. PubMed ID: 16790843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant hepatitis delta antigen from E. coli promotes hepatitis delta virus RNA replication only from the genomic strand but not the antigenomic strand.
    Sheu GT; Lai MM
    Virology; 2000 Dec; 278(2):578-86. PubMed ID: 11118380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deleterious effects of hepatitis delta virus replication on host cell proliferation.
    Wang D; Pearlberg J; Liu YT; Ganem D
    J Virol; 2001 Apr; 75(8):3600-4. PubMed ID: 11264349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus.
    Zahn RC; Schelp I; Utermöhlen O; von Laer D
    J Virol; 2007 Jan; 81(2):457-64. PubMed ID: 17020943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of ADAR1 editing of hepatitis delta virus RNAs.
    Casey JL
    Curr Top Microbiol Immunol; 2012; 353():123-43. PubMed ID: 21732238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications.
    Hsu SC; Syu WJ; Sheen IJ; Liu HT; Jeng KS; Wu JC
    Hepatology; 2002 Mar; 35(3):665-72. PubMed ID: 11870382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis delta virus minimal substrates competent for editing by ADAR1 and ADAR2.
    Sato S; Wong SK; Lazinski DW
    J Virol; 2001 Sep; 75(18):8547-55. PubMed ID: 11507200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients.
    Le Gal F; Gordien E; Affolabi D; Hanslik T; Alloui C; Dény P; Gault E
    J Clin Microbiol; 2005 May; 43(5):2363-9. PubMed ID: 15872267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis delta virus RNA editing is highly specific for the amber/W site and is suppressed by hepatitis delta antigen.
    Polson AG; Ley HL; Bass BL; Casey JL
    Mol Cell Biol; 1998 Apr; 18(4):1919-26. PubMed ID: 9528763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.